Spirituality, Religiosity, and Immune Functioning

This study has been completed.

First Received on August 7, 2003. Last Updated on June 23, 2005 History of Changes

Sponsor:	National Center for Complementary and Alternative Medicine (NCCAM)
Information provided by:	National Center for Complementary and Alternative Medicine (NCCAM)
ClinicalTrials.gov Identifier:	NCT00066924

Purpose

The purpose of this study is to determine whether religiosity and spirituality are related to immune functioning, as measured by interleukin-6 blood plasma level, among terminally ill cancer patients.

Condition
Cancer Depression Dying Process

Study Type:	Observational
Study Design:	Observational Model: Defined Population Primary Purpose: Screening Time Perspective: Cross-Sectional Time Perspective: Prospective

Resource links provided by NLM:

MedlinePlus related topics: Cancer Depression

U.S. FDA Resources

Further study details as provided by National Center for Complementary and Alternative Medicine (NCCAM):

Estimated Enrollment:	120
Study Start Date:	September 2003
Estimated Study Completion Date:	June 2004

Eligibility

Ages Eligible for Study:	21 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion criteria:

Inpatient at Calvary Hospital
Diagnosis of terminal cancer
Score of 20 or above on Mini-Mental State Exam

Exclusion criteria:

Presence of a psychiatric disorder that would preclude the production of meaningful data

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00066924

Locations

United States, New York
Calvary Hospital
Bronx, New York, United States

Sponsors and Collaborators

National Center for Complementary and Alternative Medicine (NCCAM)

Investigators

Principal Investigator:	Barry Rosenfeld, PhD	Fordham University
Principal Investigator:	William Breitbart, MD	Memorial Sloan-Kettering Cancer Center

More Information

Publications:

McClain CS, Rosenfeld B, Breitbart W. Effect of spiritual well-being on end-of-life despair in terminally-ill cancer patients. Lancet. 2003 May 10;361(9369):1603-7.

ClinicalTrials.gov Identifier:	NCT00066924 History of Changes
Other Study ID Numbers:	F31 AT001769-01
Study First Received:	August 7, 2003
Last Updated:	June 23, 2005
Health Authority:	United States: Federal Government

Keywords provided by National Center for Complementary and Alternative Medicine (NCCAM):

spirituality
religiosity
immune functioning
psychoneuroimmunology

cytokines
cancer
death
depression

Additional relevant MeSH terms:

Depression
Depressive Disorder
Behavioral Symptoms
Mood Disorders
Mental Disorders

ClinicalTrials.gov processed this record on February 09, 2012